CRACK MEDICINE

TL;DR Rheum: Amyloidosis (AL vs. AA) is a high-yield MRCP Part 1 topic that tests your ability to distinguish plasma cell–related AL amyloidosis from inflammation-driven AA amyloidosis. Focus on underlying causes, organ involvement (especially cardiac vs renal), and investigations such as serum electrophoresis and biopsy. Remember: AL = light chains + myeloma; AA = chronic inflammation + serum amyloid A. Why this matters Amyloidosis is a classic integrative topic in MRCP Par

TL;DR Sarcoidosis: Systemic Manifestations are frequently tested in MRCP Part 1 , especially extra-pulmonary features involving skin, eyes, calcium metabolism, and the heart. Recognising classic syndromes such as Löfgren’s and distinguishing sarcoidosis from tuberculosis are key exam skills. Focus on multi-organ patterns, diagnostic clues, and common pitfalls. High-yield revision of systemic involvement can significantly improve scoring. Why this matters Sarcoidosis is a mult

TL;DR Rheum: Behcet’s Disease & IgG4 Disease are high-yield topics in MRCP Part 1, focusing on recognising multisystem patterns and avoiding diagnostic traps. Behcet’s disease presents with recurrent oral ulcers, genital ulcers, and uveitis, while IgG4-related disease is a fibroinflammatory condition that mimics malignancy but responds well to steroids. Mastering hallmark features, biopsy clues, and key differentials is essential for exam success. Why this matters In MRCP Par

TL;DR Polymyalgia Rheumatica vs. Giant Cell Arteritis is a classic high-yield pairing for MRCP Part 1. PMR presents with proximal stiffness and raised inflammatory markers, while GCA is a large-vessel vasculitis causing headache, jaw claudication, and risk of blindness. Both conditions are closely related and steroid-responsive, but GCA requires urgent treatment to prevent irreversible complications. Why this matters In MRCP Part 1 , rheumatology questions frequently test pat

TL;DR Rheum: Inflammatory Myositis (Polymyositis/DM) is a core MRCP Part 1 topic centred on proximal muscle weakness, characteristic dermatological signs, and autoantibody profiles. Distinguishing polymyositis, dermatomyositis, and inclusion body myositis is essential for scoring well. Focus on CK elevation, malignancy associations, and antibody patterns. Expect clinically oriented MCQs testing subtle differentiators. Why this matters Inflammatory myopathies are consistently

TL;DR Sjögren’s Syndrome & Mixed CTD are high-yield rheumatology topics for MRCP Part 1, commonly tested through antibody profiles, systemic features, and complications. Focus on anti-Ro/La antibodies and lymphoma risk in Sjögren’s, and anti-U1 RNP with pulmonary hypertension in Mixed CTD. Questions often rely on subtle clinical clues rather than long stems. Why this matters In MRCP Part 1 , rheumatology questions often test pattern recognition rather than recall alone . Sjög

TL;DR Rheum: Systemic Sclerosis (Limited vs. Diffuse) is a high-yield MRCP Part 1 topic focused on differentiating disease subsets by skin involvement, antibodies, and complications. Limited disease (CREST) progresses slowly and is linked to pulmonary hypertension, whereas diffuse disease is aggressive with early organ fibrosis, especially lungs and kidneys. Recognising subtype patterns and antibody associations is essential for scoring marks in exam questions. Why this matte

TL;DR Rheum: Psoriatic Arthritis & Reiter’s Syndrome are core seronegative spondyloarthropathies tested in MRCP Part 1 via pattern recognition. Psoriatic arthritis is suggested by DIP involvement, nail changes and dactylitis, whereas reactive arthritis follows a recent GU/GI infection with asymmetric oligoarthritis, conjunctivitis and urethritis. Focus on distinguishing features, imaging clues, and first-line management. Avoid traps such as misclassifying DIP disease as rhe

TL;DR Rheum: Ankylosing Spondylitis & SpA is a core topic in MRCP Part 1, frequently tested via clinical patterns, imaging, and extra-articular manifestations. Focus on recognising inflammatory back pain, HLA-B27 association, and early MRI findings. Distinguishing axial from peripheral disease and identifying associated conditions such as uveitis are essential scoring areas. Mastery of these patterns improves speed and accuracy in exam scenarios. Why this matters Spondyloarth

TL;DR For MRCP Part 1 , hematology is a high-yield subject where recognising lab patterns and classic associations is key to scoring quickly. This guide on MRCP Part 1 hematology high yield facts summarises 50 essential points across anaemia, haemolysis, coagulation, malignancy, and transfusion medicine. Use it for rapid revision and pair it with MCQs for maximum retention. Why this matters Hematology is consistently tested in MRCP Part 1 , often through pattern-based MCQs r

TL;DR Heme: 25 Practice MCQs (Hematology): MRCP Part 1 is best approached through pattern recognition, lab interpretation, and repeated MCQ practice. For MRCP Part 1, hematology commonly tests anaemia, haemolysis, malignancy, and coagulation disorders. This guide outlines high-yield topics, provides a representative MCQ, and offers a practical checklist to maximise exam performance. Why this matters Hematology forms a core component of MRCP Part 1, with questions designed to

TL;DR Bone marrow failure syndromes—especially aplastic anaemia and paroxysmal nocturnal haemoglobinuria (PNH)—are frequently tested in MRCP Part 1 due to their overlapping features and distinctive diagnostic clues. Focus on pancytopenia patterns, haemolysis markers, and confirmatory tests like flow cytometry. Recognising key differences (e.g. hypocellular marrow vs complement-mediated haemolysis) is essential for exam success. This guide distils high-yield facts, pitfalls, a

TL;DR Transfusion medicine is a high-yield topic in MRCP Part 1 , particularly blood products and transfusion reactions. Focus on recognising indications, differentiating acute reactions (TRALI vs TACO), and knowing immediate management steps. Most questions test pattern recognition—learn the clinical clues and act fast. Why this matters Transfusion medicine consistently appears in MRCP Part 1 because it bridges haematology, immunology, and acute clinical care. Candidates ar

TL;DR For MRCP Part 1 , myeloproliferative neoplasms (PV, ET, and myelofibrosis) are high-yield due to their overlapping features and exam-favoured laboratory distinctions. Focus on JAK2 mutations, erythropoietin levels, thrombotic risk, and blood film findings . Recognising key differentiators—especially low EPO in PV and tear-drop cells in myelofibrosis—will help you avoid common traps. Why this matters Myeloproliferative neoplasms (MPNs) are a core haematology topic in MR

TL;DR For MRCP Part 1 , distinguishing Hodgkin’s lymphoma (HL) from non-Hodgkin’s lymphoma (NHL) is a classic, high-yield topic. HL presents with contiguous lymph node spread and Reed–Sternberg cells, whereas NHL is heterogeneous with frequent extranodal involvement. Master the clinical patterns, staging, and key associations (EBV, HIV, H. pylori ) to secure easy marks. This guide distils the most tested concepts, pitfalls, and revision essentials. Why this matters Lymphoma

TL;DR For MRCP Part 1 , dermatology questions frequently test the drug of choice for classic conditions. This drug of choice cheatsheet — dermatology focus (MRCP Part 1) summarises the most examinable treatments, escalation steps, and pitfalls. Focus on pattern recognition and first-line therapies. Use this guide for rapid revision before mocks and the exam. Why this matters Dermatology in MRCP Part 1 is deceptively high yield. Questions are rarely about obscure diseases—t

TL;DR For MRCP Part 1 , distinguishing Von Willebrand Disease vs. Hemophilia A/B relies on recognising bleeding patterns, inheritance, and lab findings. VWD presents with mucocutaneous bleeding and platelet dysfunction , whereas haemophilia causes deep tissue bleeding due to factor deficiencies . Focus on APTT, bleeding time, and response to desmopressin —these are repeatedly tested. Mastering this distinction can secure easy exam marks. Why this matters Bleeding disorders a

TL;DR For MRCP Part 1 , mastering who to test and when to test for thrombophilia is more important than memorising every disorder. Thrombophilia screening is indicated in selected patients—such as young individuals with unprovoked or recurrent VTE—but should not be done routinely. Testing must be timed correctly, avoiding the acute phase and anticoagulation, to prevent misleading results. Why this matters Thrombophilia screening is a classic MRCP Part 1 topic because it te

TL;DR Platelet Disorders: ITP vs. TTP vs. HUS MRCP Part 1 is a core exam topic requiring rapid differentiation between isolated thrombocytopenia and thrombotic microangiopathies. ITP presents with isolated platelet destruction, while TTP and HUS involve haemolysis and organ dysfunction. Recognising neurological features (TTP), renal failure (HUS), and isolated thrombocytopenia (ITP) is key to scoring marks quickly. Why this matters Platelet disorders are a frequent testing d

TL;DR Hemolytic Anemias: Autoimmune vs. Hereditary is a high-yield MRCP Part 1 topic centred on distinguishing immune-mediated destruction from intrinsic red cell defects. Autoimmune haemolysis is Coombs-positive and typically acquired, whereas hereditary causes are Coombs-negative and often lifelong. The exam frequently tests subtle lab clues such as reticulocytosis, LDH, and peripheral smear findings. Clear pattern recognition is key to scoring consistently in haematology